We are writing to you regarding the REACH Committee Meeting that will take place on
September 17-18, 2019.
Crucial discussions (and potentially votes) are planned during this meeting, on a large number of authorisation proposals for Cr VI substances. These authorisations disregard both the Judgment T-837-16 (the General Court in Sweden vs Commission) and the European Parliament’s objection to another authorisation granted on certain uses of chromium trioxide (Lanxess Deutschland GmbH and others) – as they ignore available alternatives and/or leave to companies the final decision on whether the conditions set by REACH to obtain an authorisation are met for each specific use.
Other important discussions/votes will take place regarding several restriction processes as well as the amendment of REACH article 41(5)…